Lycopodium Limited Logo

Lycopodium Limited

LYL.AX

(3.2)
Stock Price

10,25 AUD

23.6% ROA

40.44% ROE

8.78x PER

Market Cap.

449.182.549,00 AUD

9.85% DER

6.75% Yield

14.72% NPM

Lycopodium Limited Stock Analysis

Lycopodium Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Lycopodium Limited Fundamental Stock Analysis
# Analysis Rating
1 Dividend

Investors can take comfort in the company's unwavering commitment to dividends, as it has consistently distributed payouts over the past five years, ensuring a reliable income stream.

2 ROE

ROE surpassing expectations (43.54%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

3 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

4 DER

The stock has a minimal amount of debt (17%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

5 Net Profit Growth

Throughout the last three years, this company has experienced consistent net profit growth, reflecting a robust financial performance and making it an attractive investment prospect.

6 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

7 Dividend Growth

Investors can be encouraged by the company's strong dividend growth over the past three years, highlighting its ability to generate consistent returns and provide an attractive investment opportunity.

8 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (100) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

10 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

11 PBV

The stock's elevated P/BV ratio (4.11x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

Lycopodium Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Lycopodium Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Hold

Lycopodium Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Lycopodium Limited Revenue
Year Revenue Growth
2003 30.119.000
2004 53.077.000 43.25%
2005 68.141.639 22.11%
2006 83.403.830 18.3%
2007 103.752.827 19.61%
2008 119.632.819 13.27%
2009 145.968.553 18.04%
2010 119.651.542 -21.99%
2011 168.588.842 29.03%
2012 230.980.469 27.01%
2013 244.995.894 5.72%
2014 154.765.985 -58.3%
2015 122.811.322 -26.02%
2016 124.460.218 1.32%
2017 216.616.442 42.54%
2018 192.647.452 -12.44%
2019 152.223.443 -26.56%
2020 206.655.815 26.34%
2021 158.062.505 -30.74%
2022 228.711.210 30.89%
2023 323.879.383 29.38%
2024 678.919.584 52.29%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Lycopodium Limited Research and Development Expenses
Year Research and Development Expenses Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Lycopodium Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2003 15.403.000
2004 23.772.000 35.21%
2005 32.073.102 25.88%
2006 40.314.142 20.44%
2007 41.380.730 2.58%
2008 59.980.068 31.01%
2009 75.673.413 20.74%
2010 72.094.399 -4.96%
2011 97.455.062 26.02%
2012 128.376.260 24.09%
2013 136.775.550 6.14%
2014 99.898.347 -36.91%
2015 73.428.036 -36.05%
2016 65.936.117 -11.36%
2017 69.950.581 5.74%
2018 76.140.074 8.13%
2019 74.785.913 -1.81%
2020 68.191.068 -9.67%
2021 63.667.286 -7.11%
2022 86.977.120 26.8%
2023 115.767.422 24.87%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Lycopodium Limited EBITDA
Year EBITDA Growth
2003 2.857.000
2004 8.406.000 66.01%
2005 9.035.690 6.97%
2006 11.695.874 22.74%
2007 13.683.937 14.53%
2008 19.382.038 29.4%
2009 19.518.798 0.7%
2010 21.035.411 7.21%
2011 26.446.940 20.46%
2012 33.886.491 21.95%
2013 30.958.316 -9.46%
2014 6.539.973 -373.37%
2015 -2.753.498 337.52%
2016 5.475.678 150.29%
2017 14.535.632 62.33%
2018 37.100.653 60.82%
2019 9.035.554 -310.61%
2020 20.308.630 55.51%
2021 23.317.000 12.9%
2022 41.947.100 44.41%
2023 63.270.810 33.7%
2024 117.546.760 46.17%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Lycopodium Limited Gross Profit
Year Gross Profit Growth
2003 27.916.000
2004 52.010.000 46.33%
2005 66.997.946 22.37%
2006 82.444.944 18.74%
2007 103.606.333 20.42%
2008 119.209.718 13.09%
2009 145.342.553 17.98%
2010 119.234.030 -21.9%
2011 168.371.848 29.18%
2012 230.141.034 26.84%
2013 239.330.258 3.84%
2014 22.918.151 -944.28%
2015 13.273.211 -72.66%
2016 21.738.181 38.94%
2017 32.411.029 32.93%
2018 54.154.195 40.15%
2019 29.513.083 -83.49%
2020 24.336.356 -21.27%
2021 42.993.500 43.4%
2022 42.377.075 -1.45%
2023 80.345.183 47.26%
2024 141.205.324 43.1%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Lycopodium Limited Net Profit
Year Net Profit Growth
2003 65.000
2004 -204.000 131.86%
2005 -225.800 9.65%
2006 7.594.076 102.97%
2007 8.897.663 14.65%
2008 12.477.268 28.69%
2009 14.170.418 11.95%
2010 16.058.468 11.76%
2011 17.162.237 6.43%
2012 22.143.034 22.49%
2013 21.931.946 -0.96%
2014 3.878.969 -465.41%
2015 -918.077 522.51%
2016 3.163.478 129.02%
2017 10.292.083 69.26%
2018 18.170.186 43.36%
2019 16.507.378 -10.07%
2020 11.803.953 -39.85%
2021 14.199.449 16.87%
2022 27.177.701 47.75%
2023 46.780.431 41.9%
2024 82.993.004 43.63%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Lycopodium Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 1 0%
2013 1 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 1 0%
2023 1 100%
2024 2 50%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Lycopodium Limited Free Cashflow
Year Free Cashflow Growth
2003 -312.000
2004 2.161.000 114.44%
2005 6.391.187 66.19%
2006 7.590.629 15.8%
2007 6.477.226 -17.19%
2008 4.757.546 -36.15%
2009 22.955.462 79.27%
2010 10.883.961 -110.91%
2011 17.175.742 36.63%
2012 16.143.469 -6.39%
2013 21.140.018 23.64%
2014 5.778.765 -265.82%
2015 1.253.061 -361.17%
2016 9.518.063 86.83%
2017 48.996.917 80.57%
2018 -2.893.718 1793.22%
2019 -486.251 -495.11%
2020 62.256.135 100.78%
2021 -15.819.583 493.54%
2022 37.722.142 141.94%
2023 15.381.584 -145.24%
2024 18.621.845 17.4%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Lycopodium Limited Operating Cashflow
Year Operating Cashflow Growth
2003 0
2004 2.791.000 100%
2005 7.226.085 61.38%
2006 8.380.674 13.78%
2007 7.559.175 -10.87%
2008 5.393.549 -40.15%
2009 23.797.199 77.34%
2010 11.317.147 -110.28%
2011 18.104.215 37.49%
2012 17.732.448 -2.1%
2013 23.499.096 24.54%
2014 6.661.934 -252.74%
2015 1.474.396 -351.84%
2016 10.066.670 85.35%
2017 49.332.729 79.59%
2018 -1.840.608 2780.24%
2019 1.118.860 264.51%
2020 63.123.357 98.23%
2021 -12.913.934 588.8%
2022 41.675.428 130.99%
2023 19.793.933 -110.55%
2024 19.348.925 -2.3%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Lycopodium Limited Capital Expenditure
Year Capital Expenditure Growth
2003 312.000
2004 630.000 50.48%
2005 834.898 24.54%
2006 790.045 -5.68%
2007 1.081.949 26.98%
2008 636.003 -70.12%
2009 841.737 24.44%
2010 433.186 -94.31%
2011 928.473 53.34%
2012 1.588.979 41.57%
2013 2.359.078 32.64%
2014 883.169 -167.12%
2015 221.335 -299.02%
2016 548.607 59.66%
2017 335.812 -63.37%
2018 1.053.110 68.11%
2019 1.605.111 34.39%
2020 867.222 -85.09%
2021 2.905.649 70.15%
2022 3.953.286 26.5%
2023 4.412.349 10.4%
2024 727.080 -506.86%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Lycopodium Limited Equity
Year Equity Growth
2003 0
2004 16.726.000 100%
2005 21.977.432 23.89%
2006 25.259.457 12.99%
2007 28.306.868 10.77%
2008 33.849.700 16.37%
2009 39.727.300 14.79%
2010 44.719.435 11.16%
2011 49.687.094 10%
2012 59.879.587 17.02%
2013 69.429.817 13.76%
2014 62.879.353 -10.42%
2015 63.232.926 0.56%
2016 64.331.017 1.71%
2017 69.223.332 7.07%
2018 79.350.408 12.76%
2019 79.417.900 0.08%
2020 77.842.621 -2.02%
2021 87.673.819 11.21%
2022 99.675.420 12.04%
2023 112.964.907 11.76%
2024 127.440.186 11.36%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Lycopodium Limited Assets
Year Assets Growth
2003 0
2004 33.093.000 100%
2005 34.889.409 5.15%
2006 42.538.985 17.98%
2007 48.739.553 12.72%
2008 56.955.608 14.43%
2009 63.902.794 10.87%
2010 67.061.395 4.71%
2011 83.880.157 20.05%
2012 101.387.833 17.27%
2013 120.812.069 16.08%
2014 81.536.075 -48.17%
2015 84.034.240 2.97%
2016 87.006.268 3.42%
2017 143.406.798 39.33%
2018 141.401.803 -1.42%
2019 119.851.864 -17.98%
2020 156.664.347 23.5%
2021 169.660.896 7.66%
2022 224.121.859 24.3%
2023 219.833.508 -1.95%
2024 221.204.689 0.62%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Lycopodium Limited Liabilities
Year Liabilities Growth
2003 0
2004 16.367.000 100%
2005 12.911.977 -26.76%
2006 17.279.528 25.28%
2007 20.432.685 15.43%
2008 23.105.908 11.57%
2009 24.175.494 4.42%
2010 22.341.960 -8.21%
2011 34.193.063 34.66%
2012 41.508.246 17.62%
2013 51.382.252 19.22%
2014 18.656.722 -175.41%
2015 20.801.314 10.31%
2016 22.675.251 8.26%
2017 74.183.466 69.43%
2018 62.051.395 -19.55%
2019 40.433.964 -53.46%
2020 78.821.726 48.7%
2021 81.987.077 3.86%
2022 124.446.439 34.12%
2023 106.868.601 -16.45%
2024 93.764.503 -13.98%

Lycopodium Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
8.82
Net Income per Share
1.3
Price to Earning Ratio
8.78x
Price To Sales Ratio
1.3x
POCF Ratio
15.99
PFCF Ratio
16.79
Price to Book Ratio
3.48
EV to Sales
1.14
EV Over EBITDA
5.6
EV to Operating CashFlow
14.16
EV to FreeCashFlow
14.73
Earnings Yield
0.11
FreeCashFlow Yield
0.06
Market Cap
0,45 Bil.
Enterprise Value
0,39 Bil.
Graham Number
9.79
Graham NetNet
1.41

Income Statement Metrics

Net Income per Share
1.3
Income Quality
0.55
ROE
0.4
Return On Assets
0.23
Return On Capital Employed
0.44
Net Income per EBT
0.75
EBT Per Ebit
1.05
Ebit per Revenue
0.19
Effective Tax Rate
0.28

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.23
Operating Profit Margin
0.19
Pretax Profit Margin
0.2
Net Profit Margin
0.15

Dividends

Dividend Yield
0.07
Dividend Yield %
6.75
Payout Ratio
0.64
Dividend Per Share
0.77

Operating Metrics

Operating Cashflow per Share
0.71
Free CashFlow per Share
0.69
Capex to Operating CashFlow
0.04
Capex to Revenue
0
Capex to Depreciation
0.17
Return on Invested Capital
0.33
Return on Tangible Assets
0.24
Days Sales Outstanding
113.75
Days Payables Outstanding
65.7
Days of Inventory on Hand
0.44
Receivables Turnover
3.21
Payables Turnover
5.56
Inventory Turnover
827.25
Capex per Share
0.03

Balance Sheet

Cash per Share
1,75
Book Value per Share
3,26
Tangible Book Value per Share
3.1
Shareholders Equity per Share
3.28
Interest Debt per Share
0.34
Debt to Equity
0.1
Debt to Assets
0.06
Net Debt to EBITDA
-0.78
Current Ratio
2.44
Tangible Asset Value
0,12 Bil.
Net Current Asset Value
0,10 Bil.
Invested Capital
135579885
Working Capital
0,11 Bil.
Intangibles to Total Assets
0.03
Average Receivables
0,10 Bil.
Average Payables
0,04 Bil.
Average Inventory
207752
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Lycopodium Limited Dividends
Year Dividends Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 1 0%
2013 0 0%
2014 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 1 0%
2023 1 0%
2024 1 0%

Lycopodium Limited Profile

About Lycopodium Limited

Lycopodium Limited provides engineering and project delivery services in the resources, infrastructure, and industrial processes sectors. It operates through four segments: Mineral, Process Industries, Project Services-Africa, and Others. The company provides engineering and related services to junior exploration companies, multinational producers, manufacturing, and renewable energy facilities; project management, construction management, and commissioning services to the extractive mining industry; and asset management, engineering, architectural, and project delivery services to a range of private and public clients. It also offers metallurgical consulting services to mineral processing community in the field of comminution, hydrometallurgy, and mineral processing design; and drafting services to offshore entities. Lycopodium Limited was founded in 1992 and is headquartered in East Perth, Australia.

CEO
Mr. Peter De Leo B.E.
Employee
1.300
Address
1 Adelaide Terrace
East Perth, 6004

Lycopodium Limited Executives & BODs

Lycopodium Limited Executives & BODs
# Name Age
1 Mr. Karl Anthony Cicanese M.B.A.
MD of Lycopodium Minerals APAC & Executive Director
70
2 Mr. Stuart Sutherland B Surv, BE (Civil)
Managing Director of Lycopodium Infrastructure Pty Ltd
70
3 Ms. Justine Anne Campbell C.A.
Chief Financial Officer & Company Secretary
70
4 Dr. Bruno Ruggiero B.E., MAusIMM
Executive Director
70
5 Mr. Peter De Leo B.E.
MD & Executive Director
70
6 Mr. Arthur Stamos
Managing Director of Lycopodium Process Industries
70
7 Mr. Sohail Samdani
President of Lycopodium Minerals Canada Limited
70
8 Mr. Glenn Robertson
Senior Consultant of Lycopodium Process Industries Pty Ltd
70

Lycopodium Limited Competitors